ADVFN ADVFN

Hot Features

Icon for alerts 登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。
Tango Therapeutics Inc

Tango Therapeutics Inc (TNGX)

29.46
0.73
(2.54%)
終了 7月3日 5:00AM
29.02
-0.44
(-1.49%)
取引時間後: 8:59AM

Tango Therapeutics Inc (TNGX) 銘柄情報

リアルタイムのストリーミング引用、アイデア、ライブディスカッションのハブ

プレミアム

主要統計と詳細

通貨
29.02
( 1.01% )
買値
28.30
売値
29.39
出来高
2,307,617
28.60 日の範囲 30.565
5.34 52 週間の範囲 34.39
時価総額
前日終値
28.73
始値
29.00
最終取引時間
財務取引量
US$ 67,363,660
VWAP
29.1919
平均取引量 (3 か月)
US$ 4,168,535
発行済株式数
144,647,982
配当利回り
PER
-36.29
1 株当たり利益 (EPS)
-0.86
歳入
56.99M
純利益
-107.23M

Tango Therapeutics Inc について

Tango Therapeutics, Inc., a precision oncology company, focuses on the discovery and development of drugs in defined patient populations with unmet medical need. The company develops methylthioadenosine -cooperative protein arginine methyltransferase 5 (PRMT5) inhibitors, including TNG462, which is ... Tango Therapeutics, Inc., a precision oncology company, focuses on the discovery and development of drugs in defined patient populations with unmet medical need. The company develops methylthioadenosine -cooperative protein arginine methyltransferase 5 (PRMT5) inhibitors, including TNG462, which is in Phase 1/2 clinical trial for treating pancreatic and lung cancer; and TNG456, a brain-penetrant PRMT5 inhibitor for the treatment of glioblastoma. It is developing TNG260, a co-repressor of repressor element-1 silencing transcription inhibitor to reverse the immune evasion effect of serine-threonine kinase (STK) 11 loss-of-function mutations to treat lung cancer. The company was founded in 2017 and is headquartered in Boston, Massachusetts. 詳細を表示

セクター
Healthcare
業界
Biotechnology & Life Sciences
ウェブサイト
本社
Boston, United States
設立
2026
Tango Therapeutics Inc is listed in the Healthcare sector of the ナスダック市場 with ticker TNGX. The last closing price for Tango Therapeutics was US$28.73. Over the last year, Tango Therapeutics shares have traded in a share price range of US$ 5.34 to US$ 34.39.

Tango Therapeutics currently has 144,647,982 shares in issue. The market capitalisation of Tango Therapeutics is US$4.20 billion. Tango Therapeutics has a price to earnings ratio (PE ratio) of -36.29.

TNGX 最新ニュース

期間 †前日比前日比 %始値高値安値平均出来高VWAP
1-0.33-1.1243611584329.3533.5328.7699005631.10940938CS
47.5535.165346995821.4734.3919.4275701475729.9408344CS
128.9744.738154613520.0534.3919.342432932426.74448189CS
2620.17227.909604528.8534.398.66379874321.13894826CS
5223.49424.7739602175.5334.395.34318477615.68478004CS
15625.72779.3939393943.334.391.03195249411.27682788CS
26019.41201.977107189.6134.391.03128625510.97828442CS

TNGX - Frequently Asked Questions (FAQ)

What is the current Tango Therapeutics Inc share price?
The current share price of Tango Therapeutics Inc is US$ 29.02
How many Tango Therapeutics Inc shares are in issue?
Tango Therapeutics Inc has 144,647,982 shares in issue
What is the market cap of Tango Therapeutics Inc?
The market capitalisation of Tango Therapeutics Inc is USD 4.2B
What is the 1 year trading range for Tango Therapeutics Inc share price?
Tango Therapeutics Inc has traded in the range of US$ 5.34 to US$ 34.39 during the past year
What is the PE ratio of Tango Therapeutics Inc?
The price to earnings ratio of Tango Therapeutics Inc is -36.29
What is the cash to sales ratio of Tango Therapeutics Inc?
The cash to sales ratio of Tango Therapeutics Inc is 79.34
What is the registered address of Tango Therapeutics Inc?
The registered address for Tango Therapeutics Inc is 201 Brookline Avenue, Boston, Massachusetts, 02215
What is the Tango Therapeutics Inc website address?
The website address for Tango Therapeutics Inc is www.tangotx.com
Which industry sector does Tango Therapeutics Inc operate in?
Tango Therapeutics Inc operates in the Biotechnology & Life Sciences sector

TNGX 取引

さらに

取引は遅延しています

リアルタイムの取引を取得するには、アカウントをアップグレードしてください

リアルタイムにアップグレード

TNGX Discussion

投稿を表示

最近閲覧した銘柄

Delayed Upgrade Clock